Clinical Trials

250 enrolled

Urinary Bladder Neoplasms

NCT07503795 2026-03-31

Outcomes of Definitive Radiotherapy for Bladder Cancer

Not yet recruiting

300 enrolled

Urinary Bladder Neoplasms

NCT06350734 2026-03-30

Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study

704 enrolled

Urinary Bladder Neoplasms

NCT06447064 2026-03-25

(CLOCS-2)

GastrointestinalGenitourinaryGynecologic

2,900 enrolled

Urinary Bladder Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT07225127 2026-03-23

CISTO2

408 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06721260 2026-03-20

METRICS

30 enrolled

Urinary Bladder Neoplasms, Cachexia

NCT04970472 2026-03-19

MicroBlad

1,000 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasms

NCT06072027 2026-03-19

VISIOCYT2

701 enrolled

Urinary Bladder Neoplasms

NCT06109857 2026-03-16

Bladder Bank (a Prospective Banking Study)

1,500 enrolled

Urinary Bladder Neoplasms

NCT07468838 2026-03-16

UroDNA

Not yet recruiting

25 enrolled

Urinary Bladder Neoplasms, Prostatic Neoplasms

NCT03413982 2026-03-10

GUB-BCR-001

1,000 enrolled

Urinary Bladder Neoplasms

NCT06891209 2026-03-10

Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy

1,000 enrolled

Urinary Bladder Neoplasms

NCT04075305 2026-03-05

MOMENTUM

BreastCNSGastrointestinalGenitourinaryHead & NeckThoracic

8,000 enrolled

Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Genital Neoplasms, Female, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Radiation Injuries, Rectal Neoplasms

NCT05195515 2026-03-03

CONQUER

Enrolling by invitation

2,000 enrolled

Urinary Bladder Neoplasms

NCT06281691 2026-03-03

GreenBladder - Early Detection of Bladder Cancer in Residents in Greenland Using a Urinary Marker and a Mobile Cystoscopy Unit

127 enrolled

Urinary Bladder Neoplasms

NCT07088536 2026-03-03

OCCURORTW

2,000 enrolled

Urinary Bladder Neoplasms, Kidney Neoplasms, Prostatic Neoplasms, Urinary Calculi

NCT07130578 2026-03-03

The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive Bladder Cancer

60 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT07424560 2026-02-24

Multiplex Mutation Detection Using Mass Spectrometry in Bladder Cancer

400 enrolled

Urinary Bladder Neoplasms

NCT06138561 2026-02-17

Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments

180 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT07395037 2026-02-09

WASHOUT

1,050 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Hematuria, Kidney Neoplasms, Urologic Diseases

NCT03193515 2026-02-04

A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer

300 enrolled

Urinary Bladder Neoplasms

NCT03193528 2026-02-04

A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer

450 enrolled

Urinary Bladder Neoplasms

NCT03193541 2026-02-04

A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer

900 enrolled

Urinary Bladder Neoplasms

NCT04564781 2026-02-04

Predicting BCG Response

400 enrolled

Urinary Bladder Neoplasms

NCT05347342 2026-02-03

A Diagnostic for the Early Detection of Bladder Cancer

173 enrolled

Urinary Bladder Neoplasms

NCT07379255 2026-01-30

Evaluation of Postoperative Adjuvant Chemotherapy Efficacy for Bladder Cancer Based on Organoid Technology.

266 enrolled

Urinary Bladder Neoplasms

NCT07379268 2026-01-30

Evaluation of the Efficacy of Anti-HER2 Antibody-Drug Conjugates (ADC) in Locally Advanced or Metastatic Bladder Cancer Based on Organoid Technology.

224 enrolled

Urinary Bladder Neoplasms

NCT07379281 2026-01-30

Evaluating the Efficacy of Neoadjuvant Chemotherapy Drugs Based on Organoid Technology

254 enrolled

Urinary Bladder Neoplasms

NCT02012699 2026-01-22

iCaRe2

BreastCNSDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckNETOther hematologic neoplasmOther solid neoplasmPlasma cellSarcomaThoracic

999,999 enrolled

Anus Neoplasms, Bile Duct Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Duodenal Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Hypopharyngeal Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Leukemia, Lip Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Mesothelioma, Mouth Neoplasms, Multiple Myeloma, Nasopharyngeal Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Paranasal Sinus Neoplasms, Paraproteinemias, Penile Neoplasms, Peritoneal Neoplasms, Adenomatous Polyposis Coli, Prostatic Neoplasms, Rectal Neoplasms, Salivary Gland Neoplasms, Sarcoma, Skin Neoplasms, Stomach Neoplasms, Testicular Neoplasms, Thymus Neoplasms, Thyroid Neoplasms, Ureteral Neoplasms, Urethral Neoplasms, Vaginal Neoplasms, Central Nervous System Neoplasms, Thyroid Nodule, Endometrial Neoplasms, Neuroendocrine Tumors, Gastrointestinal Stromal Tumors

NCT01050504 2026-01-15

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

1,500 enrolled

Urinary Bladder Neoplasms, Prostatic Neoplasms

NCT00848289 2026-01-14

Genetic Susceptibility to Bladder Cancer

6,086 enrolled

Urinary Bladder Neoplasms, Genetic Predisposition to Disease

NCT00871754 2026-01-07

Molecular Analysis Of Bladder Cancer

5,000 enrolled

Urinary Bladder Neoplasms

NCT04964895 2025-12-17

QSCO

50 enrolled

GenitourinaryOther

Urinary Bladder Neoplasms, Sexual Dysfunction, Physiological

NCT06129084 2025-12-15

A Study to Compare the Results of FGFR Testing by Either ctDNA Blood Testing or Standard Tumor Tissue Testing

260 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT00872495 2025-12-08

Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer

500 enrolled

Urinary Bladder Neoplasms, Neoplasms

NCT04501913 2025-12-05

Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes

GastrointestinalGenitourinaryGynecologic

22 enrolled

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms, Colorectal Neoplasms

NCT07265414 2025-12-04

DRG Mutations in Prostate Cancer: a Guiding Light for Enhanced Screening and Personalised Therapy

320 enrolled

Urinary Bladder Neoplasms, Prostatic Neoplasms

NCT05630131 2025-11-28

ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy

1 enrolled

Urinary Bladder Neoplasms

NCT07251946 2025-11-26

Development of Multiphasic CT-based Delta-Radiomics Model for Predicting Postoperative Recurrence Risk in Bladder Cancer

316 enrolled

Urinary Bladder Neoplasms

NCT04412070 2025-11-21

ALU

Terminated

20 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT03933826 2025-11-04

CISTO

570 enrolled 27 charts

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Neoplasms, Neoplasms by Site, Recurrence, Urogenital Neoplasms, Urologic Diseases

NCT06310759 2025-10-10

UROSCOUT-1

3,000 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT05649306 2025-10-03

Gender Related Coping and Survivorship for Genitourinary Cancers

80 enrolled

Urinary Bladder Neoplasms, Urogenital Neoplasms

NCT06727214 2025-09-30

AssiutU

Not yet recruiting

87 enrolled